A Pilot Study of Blood-Based Methylation Markers Associated With Pancreatic Cancer

Over the past several decades in the United States, incidence of pancreatic cancer (PCa) has increased, with the 5-year survival rate remaining extremely low at 10.8%. Typically, PCa is diagnosed at an advanced stage, with the consequence that there is more tumor heterogeneity and increased probabil...

Descripción completa

Detalles Bibliográficos
Autores principales: Jansen, Rick J., Orr, Megan, Bamlet, William R., Petersen, Gloria M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963849/
https://www.ncbi.nlm.nih.gov/pubmed/35360846
http://dx.doi.org/10.3389/fgene.2022.849839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963849/
https://www.ncbi.nlm.nih.gov/pubmed/35360846
http://dx.doi.org/10.3389/fgene.2022.849839

Ejemplares similares